Literature DB >> 19757342

[Timing of resection in patients with colorectal carcinoma and synchronous liver metastases].

U T Hopt1, O Drognitz, H Neeff.   

Abstract

Timing of surgical therapy in patients with synchronous colorectal liver metastases is becoming more complex. The standard therapy for most of the patients remains resection of the colorectal cancer first followed 6 weeks later by liver resection. Simultaneous colon and liver resection is safe and advisable in cases of minor liver resections and right-sided colon tumours. Major liver resections in combination with resection of the colorectal cancer carry the risk of increased postoperative morbidity and mortality. They should be considered for selected patients only. A pre-requisite is, in addition, special expertise of the operating surgeon in colorectal as well as in hepatobiliary surgery. If the synchronous liver metastases are near to essential anatomic structures, the liver resection should be performed before the bowel resection. The same holds if the metastases are technically resectable, but the future liver remnant seems to be too small. Using well known techniques, the future liver remnant should be increased and the liver metastases resected before treatment of the colonic primary tumour. The risk for local complications is very low when leaving the colorectal tumour in situ during treatment of liver metastases. When synchronous liver metastases are technically not resectable or carry a high risk of an R1 resection, patients should be treated first with systemic neo-adjuvant chemotherapy. If sufficient down-sizing of the metastases can be achieved, liver resection should be performed before bowel resection. A close cooperation between the oncologist and the hepatobiliary surgeon is most important, since the window for curative surgery is rather limited in these patients. In patients with resectable synchronous liver metastases, the advantage of a neoadjuvant chemotherapy has not been proven yet. (c) Georg Thieme Verlag Stuttgart-New York.

Entities:  

Mesh:

Year:  2009        PMID: 19757342     DOI: 10.1055/s-0029-1224612

Source DB:  PubMed          Journal:  Zentralbl Chir        ISSN: 0044-409X            Impact factor:   0.942


  2 in total

1.  Current state of surgical treatment of liver metastases from colorectal cancer.

Authors:  Reinhart T Grundmann
Journal:  World J Gastrointest Surg       Date:  2011-12-27

2.  Minimal invasive surgery in treatment of liver metastases from colorectal carcinomas: case studies and survival rates.

Authors:  Domenico Loffredo; Alberto Marvaso; Sandro Ceraso; Nicola Cinelli; Aldo Rocca; Mario Vitale; Michele Rossi; Eugenio Genovese; Bruno Amato; Mariapia Cinelli
Journal:  BMC Surg       Date:  2013-10-08       Impact factor: 2.102

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.